Medicare Enrolled
Dr. Raymond Kovalski, M.D
Pulmonary Disease · Phoenixville, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kovalski from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kovalski?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kovalski
Dr. Raymond Kovalski is a pulmonary disease specialist in Phoenixville, PA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Kovalski performed 3,290 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Kovalski received a total of $19,003 from 53 pharmaceutical and/or device companies across 428 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kovalski is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 3% volume in PA
$19,003 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,290
Medicare services
Top 3% in PA for pulmonary disease
Not available
Unique patients (not deduplicated)
$72
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
744 | $64 | $210 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
587 | $65 | $221 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
484 | $95 | $323 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
184 | $97 | $302 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
157 | $22 | $179 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing, airflow, and physical effort during sleep. |
149 | $34 | $192 |
| Home sleep test with portable monitor An unattended sleep study performed at home using a portable monitor that records breathing, heart rate, and oxygen levels. |
149 | $78 | $716 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
138 | $14 | $195 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
97 | $9 | $138 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
92 | $141 | $592 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
80 | $80 | $327 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
79 | $105 | $402 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
62 | $132 | $319 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
58 | $44 | $168 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
46 | $132 | $498 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
35 | $16 | $49 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
33 | $64 | $284 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
32 | $15 | $115 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
30 | $32 | $40 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
27 | $72 | $192 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
27 | $513 | $1,996 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$19,003
Total received (2018-2024)
Avg $3,167/year across 6 years
Top 11% in PA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
428
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$103
2022
$118
2021
$1,746
2020
$1,368
2019
$1,481
2018
$14,186
Payments by company (2024)
GlaxoSmithKline, LLC.
$103
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$13,959
GlaxoSmithKline, LLC.
$784
Amgen Inc.
$669
Boehringer Ingelheim Pharmaceuticals, Inc.
$298
ViiV Healthcare Company
$279
Insmed, Inc.
$251
AstraZeneca Pharmaceuticals LP
$235
Actelion Pharmaceuticals US, Inc.
$195
Merck Sharp & Dohme Corporation
$183
Mylan Specialty L.P.
$179
E.R. Squibb & Sons, L.L.C.
$174
JAZZ PHARMACEUTICALS INC.
$158
Amarin Pharma Inc.
$157
Philips Electronics North America Corporation
$116
Novo Nordisk Inc
$115
PFIZER INC.
$96
Genentech USA, Inc.
$93
Biohaven Pharmaceuticals, Inc.
$73
Jazz Pharmaceuticals Inc.
$55
AbbVie Inc.
$55
Abbott Laboratories
$54
SANOFI PASTEUR INC.
$53
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$46
HARMONY BIOSCIENCES LLC
$45
Vapotherm Inc
$44
Lilly USA, LLC
$42
SANOFI-AVENTIS U.S. LLC
$41
Janssen Biotech, Inc.
$41
Alexion Pharmaceuticals, Inc.
$39
AbbVie, Inc.
$37
Allergan Inc.
$32
Ultragenyx Pharmaceutical Inc.
$29
UCB, Inc.
$29
Sunovion Pharmaceuticals Inc.
$29
Circassia Pharmaceuticals Inc
$28
Takeda Pharmaceuticals U.S.A., Inc.
$24
Mallinckrodt LLC
$22
Harmony Biosciences LLC
$20
Merck Sharp & Dohme LLC
$19
Nestle HealthCare Nutrition Inc.
$17
Esperion Therapeutics, Inc.
$16
Bayer HealthCare Pharmaceuticals Inc.
$16
HeartFlow, Inc.
$16
Teva Pharmaceuticals USA, Inc.
$16
Nabriva Therapeutics, plc
$15
KCI USA, Inc.
$15
Regeneron Healthcare Solutions, Inc.
$14
Advanced Respiratory, Inc
$14
bioMerieux
$14
Gilead Sciences, Inc.
$13
Kowa Pharmaceuticals America, Inc.
$13
Eisai Inc.
$13
Sanofi Pasteur Inc.
$12
Top 3 companies account for 81.1% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACTHAR · ADACEL · ANORO · ANORO ELLIPTA · AREXVY · Aimovig · Arikayce · Assurity Pacemaker · BELSOMRA · BEXSERO · BREO · BREZTRI · BREZTRI AEROSPHERE · CREON · Cimzia · Corlanor · Creon · Crysvita · DALVANCE · DOVATO · DUPIXENT · Dayvigo · ELIQUIS · EVENITY · FARXIGA · FASENRA · FLUZONE QUADRIVALENT · INVOKANA · JANUVIA · JARDIANCE · JULUCA · Kerendia · LINZESS · LONHALA MAGNAIR · Livalo · NEXLETOL · NUCALA · NURTEC ODT · OFEV · OPSUMIT · OPSUMIT MACITENTAN · Otezla · Ozempic · PENTACEL · PRALUENT · PREVNAR - 13 · PREVNAR 13 · Perforomist · Precision Flow · Prolia · QULIPTA · Repatha · SIMPONI ARIA · SOLIRIS · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · SYNVISC-ONE · Saxenda · Strensiq · TAKHZYRO · TIVICAY · TRADJENTA · TRELEGY ELLIPTA · TRIUMEQ · TRULICITY · TUDORZA PRESSAIR · The Vest System Model 105 Home Care · Tresiba · UBRELVY · VAC ULTA · VAPOTHERM · VERQUVO · VRAYLAR · Vascepa · Wakix · Wegovy · XARELTO · XIFAXAN · XYREM · XYWAV · Xenleta · Xolair · Yupelri · ZENPEP · inCourage
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Pulmonary diseases in nearby ZIP areas
219
County median income
$123,041
Nearest hospital to ZIP centroid (approximate)
PHOENIXVILLE HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kovalski is a clinical cardiology specialist, with above-average Medicare volume (top 3% in PA), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kovalski experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Kovalski performed 744 hospital follow-up visit, moderate complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Kovalski receive payments from pharmaceutical companies?
Yes. Dr. Kovalski received a total of $19,003 from 53 companies across 428 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kovalski's costs compare to other pulmonary diseases in Phoenixville?
Dr. Kovalski's average Medicare payment per service is $72. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kovalski) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Phoenixville
Browse pulmonary diseases in Phoenixville ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in PA
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in PA
Which PA pulmonary diseases receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology